Testing effectiveness (Phase 2)Study completedNCT04307186
What this trial is testing
Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions
Who this might be right for
Central Nervous System Pathology
Bayer 57